MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12028-013-9904-4

Медицинская библиотека · Neurocritical care · 2014

Safety evaluation of nasopharyngeal cooling (RhinoChill®) in stroke patients: an observational study.

Poli Sven, Purrucker Jan, Priglinger Miriam, Sykora Marek, Diedler Jennifer, Rupp André, Bulut Cem, Hacke Werner, Hametner Christian

Оценочное исследованиеСтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

New technologies for therapeutic cooling have become available. The objective of our study was to investigate the safety of nasopharyngeal cooling with the RhinoChill(®) device in stroke patients, focusing on systemic and neurovital parameters.

METHODS

In this prospective observational study, consecutive patients with severe ischemic or hemorrhagic stroke who underwent intracranial pressure (ICP) and brain temperature monitoring have been enrolled. Ten patients who were treated with the RhinoChill(®) device were analyzed. Brain and bladder temperature and systemic and neurovital parameters were monitored continuously. Additional evaluations of safety included bleeding complications and otolaryngological examinations.

RESULTS

Baseline brain temperature of 36.7 °C (SD 0.9) decreased by an average of 1.21 °C (SD 0.46) within 1 h, the effect of brain temperature decrease ranged from a maximum of 2 °C (patients 3 and 7) to a minimum of 0.6 °C (patient 4). Within the first several minutes after initiating RhinoChill(®) treatment, 3 of 10 patients experienced an increase in systolic arterial pressure by 30, 30, and 53 mmHg, respectively. Heart rate rose as well (mean 3 bpm, SD 2.9). ICP and oxygen saturation were unaffected by the treatment. We observed 1 bleeding complication in the control CT scan of patient 10. Rhinoscopical findings 3 days after nasopharyngeal cooling and at the follow-up (>6 months) and a 16-item smell test were normal.

CONCLUSION

The RhinoChill(®) system cools the brain efficiently. However, steep increases in blood pressure raise serious concerns regarding the safety of its use in stroke patients.

Для цитирования: Poli Sven, Purrucker Jan, Priglinger Miriam, Sykora Marek, Diedler Jennifer, Rupp André, Bulut Cem, Hacke Werner, Hametner Christian. Safety evaluation of nasopharyngeal cooling (RhinoChill®) in stroke patients: an observational study.. Neurocritical care. 2014. DOI: 10.1007/s12028-013-9904-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.